Clinicopathologic correlation of beclin-1 expression in pancreatic ductal adenocarcinoma

Pathology Research and Practice

Volumn 207, Issue 4, 2011, Pages 247-252

  Kim, Hyun Soo ^a   Lee, Sun Ho ^a   Do, Sung Im ^a   Lim, Sung Jig ^a   Park, Yong Koo ^a   Kim, Youn Wha ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Beclin 1; Immunohistochemistry; Pancreatic ductal carcinoma

Indexed keywords

BECLIN 1;

ACINAR CELL; ADULT; AGED; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREAS ISLET CELL; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, PANCREATIC DUCTAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 79955166274     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.02.007     Document Type: Article

References (23)

1. Jung K.W., Yim S.H., Kong H.J. Cancer survival in Korea 1993-2002: a population-based study. J. Korean Med. Sci. 2007, 22(Suppl.):S5-S10.
2. Bassi C., Falconi M., Salvia R., Mascetta G., Molinari E., Pederzoli P. Management of complications after pancreaticoduodenectomy in a high volume centre: results on 150 consecutive patients. Dig. Surg. 2001, 18:453-457. (discussion 458).
3. Edinger A.L., Thompson C.B. Defective autophagy leads to cancer. Cancer Cell 2003, 4:422-424.
4. Levine B. Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell 2005, 120:159-162.
5. Gozuacik D., Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004, 23:2891-2906.
6. Ogier-Denis E., Codogno P. Autophagy: a barrier or an adaptive response to cancer. Biochim. Biophys. Acta 2003, 1603:113-128.
7. Klionsky D.J., Cregg J.M., Dunn W.A. A unified nomenclature for yeast autophagy-related genes. Dev. Cell 2003, 5:539-545.
8. Aita V.M., Liang X.H., Murty V.V. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999, 59:59-65.
9. Liang X.H., Jackson S., Seaman M. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
10. Chen Y., Lu Y., Lu C., Zhang L. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to Hypoxia-Inducible Factor (HIF)-1alpha expression. Pathol. Oncol. Res. 2009.
11. Ding Z.B., Shi Y.H., Zhou J. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res. 2008, 68:9167-9175.
12. Miracco C., Cosci E., Oliveri G. Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int. J. Oncol. 2007, 30:429-436.
13. Shen Y., Li D.D., Wang L.L., Deng R., Zhu X.F. Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy 2008, 4:1067-1068.
14. Ahn C.H., Jeong E.G., Lee J.W. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS 2007, 115:1344-1349.
15. Li B.X., Li C.Y., Peng R.Q. The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy 2009, 5:303-306.
16. Chen N., Karantza-Wadsworth V. Role and regulation of autophagy in cancer. Biochim. Biophys. Acta 2009, 1793:1516-1523.
17. Won K.Y., Kim G.Y., Kim Y.W., Song J.Y., Lim S.J. Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer. Hum. Pathol. 2010, 41:107-112.
18. Huang X., Bai H.M., Chen L., Li B., Lu Y.C. Reduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors. J. Clin. Neurosci. 2010, 17:1515-1519.
19. Edinger A.L., Thompson C.B. Death by design: apoptosis, necrosis and autophagy. Curr. Opin. Cell Biol. 2004, 16:663-669.
20. Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 2005, 5:726-734.
21. Miracco C., Cevenini G., Franchi A. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum. Pathol. 2010, 41:503-512.
22. Yoshioka A., Miyata H., Doki Y. LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers. Int. J. Oncol. 2008, 33:461-468.
23. Fujii S., Mitsunaga S., Yamazaki M. Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci. 2008, 99:1813-1819.